Peptide Library / Detail
Cartalax
Half-life
Estimated 1-3 hours (typical for short tripeptides)
Delivery
Subcutaneous or intramuscular injection
Dosage
—
Research Use Only
All products listed are for laboratory research only — not for human consumption. By browsing, you acknowledge these terms.
Purchase
Description
Cartalax is a synthetic tripeptide (Ala-Glu-Asp) developed as part of the Khavinson peptide bioregulator family. It is designed to support tissue regeneration and cellular function, particularly in cartilage, musculoskeletal tissues, and aging organs. Research suggests it may modulate gene expression and influence stem cell differentiation and proliferation processes.
Usage
Research protocols typically involve subcutaneous or intramuscular administration at doses ranging from 10-20 mcg per injection, administered 1-2 times daily for cycles of 10-20 days. Some protocols suggest periodic cycling (e.g., 10 days on, 10 days off) to support tissue repair and regeneration processes.
Mechanism of Action
Cartalax functions as a bioregulatory peptide that influences gene expression patterns in aging cells and tissues. It appears to modulate mesenchymal stem cell differentiation and proliferation, enhance cellular renewal processes in various tissues including kidney and skin, and regulate thymocyte function. The tripeptide structure allows it to interact with cellular signaling pathways involved in tissue homeostasis and regeneration.
Benefits(7)
- Supports cartilage and connective tissue regeneration
- May enhance mesenchymal stem cell function and differentiation
- Promotes cellular renewal in aging tissues
- Supports musculoskeletal tissue repair and maintenance
- May improve tissue function in aging organs including kidney and thymus
- Modulates gene expression patterns associated with cellular aging
- Supports skin fibroblast function during aging processes
Side Effects(4)
- Limited adverse effects reported in research literature
- Potential injection site reactions (redness, mild discomfort)
- Individual sensitivity or allergic reactions possible
- Long-term safety profile requires further investigation